BioMedPharm is a state research program project dedicated to the development of innovative products and technological solutions in the fields of biomedicine, medical technology, and pharmacy (2022 – 2024, grant No. VPP-EM-BIOMEDICĪNA-2022/1-0001).

Six leading research organizations in Latvia have joined forces to establish the BioMedPharm consortium, a pioneering platform capable of implementing biomedical research projects of any complexity.

BioMedPharm's core mission is to enhance patient access to treatment, thereby reducing mortality and morbidity rates and improving overall health conditions. The consortium will focus on developing medicinal products and their manufacturing technologies, transport forms, vaccines, drug repurposing, drug discovery and development, as well as identifying new biomarkers and precision medicine solutions.